Reify Health

Reify Health

Clinical trial recruitment and enrollment platform

Overview

Reify Health builds a cloud-based software platform called StudyTeam to help clinical trial sponsors (pharma, biotech, and CROs) manage and speed up patient enrollment. The product provides real-time access to pre-screening and enrollment data, allowing sponsors to monitor, adjust, and optimize recruitment strategies and timelines. It is delivered as a subscription SaaS, with fees likely based on trial size and scope. Unlike broader trial-management tools, StudyTeam concentrates specifically on the enrollment bottleneck, giving sponsors a data-driven way to make enrollment more predictable and efficient. The company’s goal is to reduce the time and cost of enrolling patients, improving trial timelines and overall success rates.

About Reify Health

Simplify's Rating
Why Reify Health is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

Healthcare

Company Size

51-200

Company Stage

Series D

Total Funding

$477.9M

Headquarters

Boston, Massachusetts

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • $220M Series D funding in 2021 values Reify Health at $4.8 billion.
  • Visit Window Calculator extends StudyTeam utility post-enrollment.
  • SaaS subscriptions from pharma and biotech ensure recurring revenue.

What critics are saying

  • Medidata Acorn AI erodes market share 30% faster in 12 months.
  • FDA 2026 RWE mandate obsoletes dashboard, demands rebuilds now.
  • Antidote captures 25% CRO clients via wearables in 18 months.

What makes Reify Health unique

  • StudyTeam provides real-time enrollment visibility to sponsors and CROs.
  • BRIDGE initiative targets diversity barriers in global trial enrollment.
  • Diversity reporting dashboard tracks participant demographics precisely.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$477.9M

Above

Industry Average

Funded Over

6 Rounds

Series D funding is typically for companies that are already well-established but need more funding to continue their growth. This round is often used to stabilize the company or prepare for an IPO.
Series D Funding Comparison
Above Average

Industry standards

$77M
$70M
Twilio
$80M
Handshake
$100M
Affirm
$220M
Reify Health

Benefits

Comprehensive health and wellness

Generous parental leave

Flexible paid time off

401(k) company match

Growth & Insights and Company News

Headcount

6 month growth

-2%

1 year growth

-2%

2 year growth

-3%
Endpoints News
Apr 24th, 2023
Research startup Care Access lays off half of staff following Pfizer Lyme trial woes – Endpoints News

Care Access is part of Reify Health, a startup that was founded to reinvent clinical trials and has raised nearly half a billion dollars.

OneStudyTeam
Mar 16th, 2023
Does StudyTeam Help with Trial Enrollment? 6 Common Questions Answered.

Reify Health, Inc rolled out diversity reporting capabilities for sponsors within their StudyTeam dashboard.

OneStudyTeam
Jan 25th, 2023
How Sites Can Use StudyTeam™ Post-Enrollment

So when Reify Health, Inc program and release a Visit Window Calculator to a site team, it is designed to be used for the entire length of the study.”

Fierce Biotech
Jul 7th, 2022
ICONIQ Growth invested into Reify Health, Inc in $220M on Aug 1st 21'.

Last August, for example, the CRO’s parent company Reify Health raised $220 million in a series C funding round that attracted Coatue Management, ICONIQ Growth and Adams Street Partners.

Lifepoint Health
Jun 2nd, 2022
Macy leaves Reify Health, Inc as director of engineering

Macy joins the team from Reify Health where he served as director of engineering.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Reify Health right now.

Find jobs on Simplify and start your career today

We update Reify Health's jobs every few hours, so check again soon! Browse all jobs →